The price of Array Biopharma continues to grow gradually within the descending channel and is now trying to gain a foothold above 4.25 and rebound from the sloping support line. In case of breaking through these levels, the company quotes may fall to 3.75 and 3.40. We expect the price growth along the inclined line of support to the upper boundary of the channel with the objectives at 4.50 and 4.75.
25.06.2014 - Array Biopharma gradually grows along the support
We would like to remind you that although trading of derivatives on margin may offer many benefits, it is important to note that it also carries a high level of risk. Please click here to read our full ‘Risk Disclosure’ and ‘Risk Disclosures for Financial Instruments & Investment Services’.
Trading of complex financial products, such as Stocks, Futures, Foreign Exchange (‘Forex’), Contracts for Difference (‘CFDs’), Indices, Options, or other financial derivatives, on ‘margin’ carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to trade any of these markets you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full ‘Risk Disclosure’ and ‘Risk Disclosures for Financial Instruments & Investment Services’
‘fxfinpro.com’ is a domain owned and operated by ‘PFX Financial Professionals Limited’, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840, having its principal place of business at 82 Nikou and Despina Pattichi Avenue, Maritania Court, Office 101, Kato Polemedia, 3070 Limassol, Cyprus. ‘PFX Financial Professionals Limited’ is regulated as a Cyprus Investment Firm (‘CIF’) by the Cyprus Securities and Exchange Commission (‘CySEC’) under license number 193/13. ‘PFX Financial Professionals Limited’ operates in accordance with the Markets in Financial Instruments Directive (‘MiFID’) of the European Union
PFX Financial Professionals Limited does not provide services to citizens of the USA, Canada, Japan, Belgium, North Korea, or Iran